Epidemiology and Health

Original Articles

Pain and mortality among older adults in Korea: Chiil Song, Wankyo Chung; Epidemiol Health. 2021;43:e2021058. Published online September 7, 2021; DOI: https://doi.org/10.4178/epih.e2021058

11,935 View
148 Download
3 Web of Science
5 Crossref

Abstract Summary PDF Supplementary Material

Abstract

OBJECTIVES
With the increasing elderly population with chronic disease, understanding pain and designing appropriate policy interventions to it have become crucial. While pain is a noted mortality risk factor, limited studies exist due to the various causes of pain and the subjectivity of pain expression. This study aimed to examine the relationship between pain and mortality, controlling for other diseases and socio-cultural factors.

METHODS

We analyzed 6,258 individuals aged 45 years or older, the population with the highest prevalence of pain, using the Korean Longitudinal Study of Aging (2006-2016) data and the Cox proportional-hazards model. Further subgroup analyses were conducted by sex and education level to examine differences in the relationship between pain and mortality.

RESULTS

The adjusted hazard ratios of mortality were 1.16 (95% confidence interval [CI], 1.00 to 1.34, model 1) and 1.12 (95% CI, 0.97 to 1.29, model 2) for the individuals in pain depending on the models used, where additional socio-cultural factors were accounted for in model 2. For individuals in severe pain, ratios were significantly higher with 1.23 (95% CI, 1.08 to 1.41, model 1) and 1.16 (95% CI, 1.02 to 1.32, model 2). Further subgroup analyses showed that severe pain was more associated with mortality for males and more educated individuals, with adjusted hazard ratios of 1.29 (95% CI, 1.08 to 1.55, model 2) and 1.62 (95% CI, 1.15 to 2.28, model 2), respectively.

CONCLUSIONS

Pain showed a statistically significant relationship with mortality risk. Family members or medical staff should pay proper attention to pain, particularly severe pain in males and highly educated individuals.

Summary

Korean summary
우리나라의 고령인구와 만성질환의 증가가 가속화됨에 따라, 통증의 문제를 겪는 인구가 증가하고 통증의 사회경제적 영향도 커지고 있어 통증에 대한 엄밀한 분석이 요구된다. 본 연구는 통증을 주로 겪는 중·고령층을 대상으로 생존분석을 통해, 통증이 객관적 지표인 사망위험과 유의미하게 관련이 있음을 보였다. 따라서 환자의 통증 표현은, 특히 남성과 고학력자의 심한 통증 표현은, 사망과 관련이 있는 중요한 지표로 관리될 필요가 있으며 적절한 정책적 접근이 요구된다.

Key Message
With the increasing elderly population with chronic disease, understanding pain and designing appropriate policy interventions to it have become crucial. This study showed that pain had a statistically significant relationship with mortality risk, thus proper attention should be paid to it.

Citations

Citations to this article as recorded by

Impact of Pain on Activities of Daily Living in Older Adults: A Cross-Sectional Analysis of Korean Longitudinal Study of Aging (KLoSA)
Ambrish Singh, Sreelatha Akkala, Minakshi Nayak, Anirudh Kotlo, Naresh Poondla, Syed Raza, Jim Stankovich, Benny Antony
Geriatrics.2024; 9(3): 65. CrossRef
Association Between Socioeconomic Inequalities in Pain and All-Cause Mortality in the China Health and Retirement Longitudinal Study: Longitudinal Cohort Study
Zhuo Zhang, Dongmei Xue, Ying Bian
JMIR Public Health and Surveillance.2024; 10: e54309. CrossRef
Assessing healthcare professionals’ perceptions of pain concepts and beliefs
Sejun Oh, Yeonji Gu, Inbeom Kim, Euha Kwon, Sangheon Lee, Kyounghae Kim
NeuroRehabilitation.2024; 55(1): 117. CrossRef
Sex-specific effects of neuropathic pain on long-term pain behavior and mortality in mice
Magali Millecamps, Susana G. Sotocinal, Jean-Sebastien Austin, Laura S. Stone, Jeffrey S. Mogil
Pain.2023; 164(3): 577. CrossRef
Spécificités de la prise en charge de la douleur chez la personne âgée
G. Pickering
Bulletin de l'Académie Nationale de Médecine.2023; 207(5): 661. CrossRef

Self-rated health as a predictor of mortality according to cognitive impairment: findings from the Korean Longitudinal Study of Aging (2006-2016): Goun Park, Wankyo Chung; Epidemiol Health. 2021;43:e2021021. Published online April 7, 2021; DOI: https://doi.org/10.4178/epih.e2021021

11,208 View
299 Download
3 Web of Science
3 Crossref

Abstract Summary PDF Supplementary Material

Abstract

OBJECTIVES
Self-rated health is an instrumental variable to assess the overall health status of a population. However, it remains questionable whether it is still useful for cognitively impaired individuals. Therefore, this study aims to analyze whether self-rated health by the cognitively impaired predicts mortality reliably.

METHODS

This study used 7,881 community-dwelling individuals, aged 45 and above, from the Korean Longitudinal Study of Aging (2006-2016). It used the Cox proportional hazard models for analysis. Cognitive status was classified based on the Korean Mini Mental State Examination score and a stratified analysis was used to determine whether the predictability of self-rated health varies according to cognitive status.

RESULTS

For cognitively intact individuals, the adjusted hazard ratios (aHR) of mortality were 2.00 (95% confidence interval [CI], 1.18 to 3.41, model 4) for those with ‘bad’ self-rated health and 2.40 (95% CI, 1.35 to 4.25, model 4) for those with ‘very bad’ self-rated heath, respectively, compared with those with ‘very good’ health. The results remain statistically significant even after adjusting for socio-demographic factors, health status, and health-related behaviors. For cognitively impaired individuals, the aHR of mortality was statistically significant for those with ‘very bad’ self-rated health, compared with those with ‘very good’ health, when socio-demographic factors were accounted for (aHR, 3.03; 95% CI, 1.11 to 8.28, model 2).

CONCLUSIONS

Self-rated health by cognitively impaired individuals remains useful in predicting mortality. It appears to be a valid and reliable health indicator for the rising population with cognitive impairment, especially caused by aging population.

Summary

Korean summary
본 연구는 인지 저하 여부에 따라 주관적 건강의 사망예측력이 달라지는지 확인하기 위해 K-MMSE 로 인지 저하 여부를 나누고 콕스 비례위험모델을 사용하여 분석을 시행하였다. 그 결과, 인지 저하군이 평가한 주관적 건강은 사망을 통계적으로 유의하게 예측하였다. 인구의 고령화로 지역 사회 내에서 인지 저하자가 지속적으로 증가하고 있는 상황에서 주관적 건강은 유효한 사망예측 인자이며 신뢰할 만한 건강지표이다.

Key Message
This study aims to analyze whether self-rated health by the cognitively impaired predicts mortality reliably. We used the Cox proportional hazard models for analysis. Cognitive status was classified based on the K-MMSE score. We found that self-rated health by cognitively impaired individuals remains useful in predicting mortality.

Citations

Citations to this article as recorded by

Factores sociodemográficos y de bienestar mediadores y moderadores de la relación entre la depresión y la demencia
Maria del Pilar Santacruz-Ortega, Bertha Lucia Avendaño, Maria Fernanda Cobo, Silvia Mejia-Arango
Neurología Argentina.2023; 15(3): 149. CrossRef
Impact of urban green space on self-rated health: Evidence from Beijing
Dongsheng Zhan, Qianyun Zhang, Mei-Po Kwan, Jian Liu, Bochuan Zhan, Wenzhong Zhang
Frontiers in Public Health.2022;[Epub] CrossRef
Association of the number of teeth and self-rated mastication with self-rated health in community-dwelling Japanese aged 40 years and older: the Yamagata cohort study
Shigeo Ishikawa, Tsuneo Konta, Shinji Susa, Kenichi Ishizawa, Naohiko Makino, Yoshiyuki Ueno, Naoki Okuyama, Mitsuyoshi Iino
Scientific Reports.2022;[Epub] CrossRef

Editorial

Current status of hepatitis C virus infection and countermeasures in South Korea: Sook-Hyang Jeong, Eun Sun Jang, Hwa Young Choi, Kyung-Ah Kim, Wankyo Chung, Moran Ki; Epidemiol Health. 2017;39:e2017017. Published online April 13, 2017; DOI: https://doi.org/10.4178/epih.e2017017

25,112 View
369 Download
16 Web of Science
26 Crossref

Abstract Summary PDF Supplementary Material

Abstract

Hepatitis C virus (HCV) infection is a major cause of liver cirrhosis, hepatocellular carcinoma, and liver-related mortality. The new antiviral drugs against HCV, direct acting antivirals, result in >90% cure rate. This review aimed to summarize the current prevalence, clinical characteristics, outcomes, and treatment response associated with HCV infection, and countermeasures for optimal HCV control in South Korea. Based on a literature review, the current anti-HCV prevalence in the Korean population is 0.6 to 0.8%, with increasing prevalence according to age. The major HCV genotypes in Korean patients were genotype 1b and genotype 2. Successful antiviral treatment leads to significantly reduced liver related complications and mortality. However, only about one third of the individuals with HCV infection seem to be managed under the current national health insurance system, suggesting a remarkable rate of underdiagnoses and subsequent loss of opportunity to cure. A recent study in South Korea showed that targeted population screening for HCV infection is cost-effective. To prevent recently developed clusters of HCV infection in some clinics, mandatory surveillance rather than sentinel surveillance for HCV infection is required and governmental countermeasures to prevent reuse of syringes or other medical devises, and public education should be maintained. Moreover, one-time screening for a targeted population should be considered and a cost-effectiveness study supporting an optimal screening strategy is warranted.

Summary

Korean summary
우리나라 C형간염 유병률은 1% 미만(0.6-0.8%)이며, 수혈에 의한 C형간염은 더 이상 발생하지 않을 것으로 보인다. 그러나 최근 의료기관에서 C형간염 집단감염이 발생하여 국가적 대응이 필요한 공중보건의 문제로 떠올랐다. 2016년 부터는 C형간염을 완치할 수 있는 효과적이고 안전한 약제가 건강보험급여로 인정되어 이미 진단된 환자들에서는 효과적인 치료가 시작되었다. 그러나 진단되지 않은 상태에서 간질환이 진행되고 있는 환자들을 발굴하기 위해 국가 검진체계와 연계하여 선별검사를 시행한다면, 단기적으로는 진단과 치료비용 부담이 커지겠지만 장기적으로 사망률을 감소시키고, 삶의 질을 높이는 비용효과적인 C형간염 퇴치 전략이 될 것이다.

Citations

Citations to this article as recorded by

Changing trends in the incidence and spectrum of cancers between 1990 and 2021 among HIV-infected patients in Busan, Korea
Soon Ok Lee, Jeong Eun Lee, Yong Ki Sim, Shinwon Lee, Woo Seog Ko, Jinmi Kim, Jin Suk Kang, Hyunjin Son, Sun Hee Lee
Journal of Infection and Chemotherapy.2023; 29(6): 571. CrossRef
Next-generation sequencing analysis of hepatitis C virus resistance–associated substitutions in direct-acting antiviral failure in South Korea
Kyung-Ah Kim, Sejoon Lee, Hye Jung Park, Eun Sun Jang, Youn Jae Lee, Sung Bum Cho, Young Suk Kim, In Hee Kim, Byung Seok Lee, Woo Jin Chung, Sang Hoon Ahn, Seungtaek Kim, Sook Hyang Jeong
Clinical and Molecular Hepatology.2023; 29(2): 496. CrossRef
Treatment of Chronic Hepatitis C in Older Adults
Jong Eun Yeon
Korean Journal of Clinical Geriatrics.2023; 24(3): 93. CrossRef
Effect of Disease-related Knowledge and Health Enhancement Lifestyle on Self-management Behavior among Chronic Hepatitis C Patients
Hoo Jeung CHO, Euna PARK
THE JOURNAL OF FISHERIES AND MARINE SCIENCES EDUCATION.2022; 34(2): 219. CrossRef
Assessing the Effectiveness and Safety of Direct-acting Antiviral Treatment in Korean Patients with Hepatitis C Virus Genotype 1b or 2 at a Tertiary Care Hospital
Mi Seon Park, Young-Mo Yang, Ki Hyun Park, Hyonok Yoon, Ju Sin Kim, Eun Joo Choi
Korean Journal of Clinical Pharmacy.2022; 32(3): 191. CrossRef
Analysis of Hepatitis C Virus Genotypes and RNA Quantitative Values in Cheonan, Republic of Korea from 2007 to 2016
Bishguurmaa Renchindorj, Bo Kyeung Jung, Joowon Park
Microbiology and Biotechnology Letters.2022; 50(3): 422. CrossRef
Comparative evaluation of Elecsys, Atellica, and Alinity assays for measuring the anti-Hepatitis C virus (HCV) antibody
Youn Keong Cho, Sinyoung Kim, Hyun Ok Kim, Da Som Choi, Hyon-Suk Kim, Younhee Park
Journal of Clinical Virology.2021; 141: 104910. CrossRef
Performance Evaluation of Aptima HBV and HCV Quant Assays in the Panther System
Yu Jeong Choi, Boyeon Kim, Yoonjung Kim, Kyung-A Lee
Laboratory Medicine Online.2021; 11(3): 177. CrossRef
Inclusion of hepatitis C virus testing in National Health Screening to accelerate HCV elimination in South Korea
Youngmee Jee
Global Health & Medicine.2021; 3(5): 288. CrossRef
Clinical Characteristics and Treatment Outcomes of Patients with Hepatitis C Virus and Human Immunodeficiency Virus Coinfection: Experience at a Single Center in Korea
Dae Hyun Lim, Jae Yoon Jeong, Seongwoo Nam, Jongkyoung Choi, Hyeok Choon Kwon, Yong Bum Yoon, Yeonjae Kim, BumSik Chin
Journal of Korean Medical Science.2021;[Epub] CrossRef
Efficacy and Safety of Glecaprevir/Pibrentasvir in Korean Patients with Chronic Hepatitis C: A Pooled Analysis of Five Phase II/III Trials
Jeong Heo, Yoon Jun Kim, Jin-Woo Lee, Ji Hoon Kim, Young-Suk Lim, Kwang-Hyub Han, Sook-Hyang Jeong, Mong Cho, Ki Tae Yoon, Si Hyun Bae, Eric D. Crown, Linda M. Fredrick, Negar Niki Alami, Armen Asatryan, Do Hyun Kim, Seung Woon Paik, Youn-Jae Lee
Gut and Liver.2021; 15(6): 895. CrossRef
A tool to measure the impact of inaction toward elimination of hepatitis C: A case study in Korea
Yong Kyun Won, Kyung Sik Kang, Yuri Sanchez Gonzalez, Homie Razavi, Ellen Dugan, Kwang-Hyub Han, Sang Hoon Ahn, Mi Young Jeon, Do Young Kim, Tatsuo Kanda
PLOS ONE.2020; 15(4): e0232186. CrossRef
Changes in Characteristics of Patients with Liver Cirrhosis Visiting a Tertiary Hospital over 15 Years: a Retrospective Multi-Center Study in Korea
Won Young Jang, Woo Jin Chung, Byoung Kuk Jang, Jae Seok Hwang, Heon Ju Lee, Moon Joo Hwang, Young Oh Kweon, Won Young Tak, Soo Young Park, Su Hyun Lee, Chang Hyeong Lee, Byung Seok Kim, Si Hye Kim, Jeong Ill Suh, Jun Gi Park
Journal of Korean Medical Science.2020;[Epub] CrossRef
Cost‐effectiveness and health‐related outcomes of screening for hepatitis C in Korean population
Kyung‐Ah Kim, Wankyo Chung, Hwa Young Choi, Moran Ki, Eun Sun Jang, Sook‐Hyang Jeong
Liver International.2019; 39(1): 60. CrossRef
Cost‐effectiveness of sofosbuvir plus ribavirin therapy for hepatitis C virus genotype 2 infection in South Korea
Wankyo Chung, Kyung‐Ah Kim, Eun Sun Jang, Moran Ki, Hwa Young Choi, Sook‐Hyang Jeong
Journal of Gastroenterology and Hepatology.2019; 34(4): 776. CrossRef
The association between hepatitis and osteoporosis: a nested case-control study using a national sample cohort
Chanyang Min, Woo Jin Bang, Miyoung Kim, Dong Jun Oh, Hyo Geun Choi
Archives of Osteoporosis.2019;[Epub] CrossRef
Apolipoprotein E Genotype and Expression Correlated with Hepatitis C Virus Genotype and Infection
Gyu-Nam Park, Hyun-Jung Jo, Hye-Ran Kim, Min-Ju Kim, Kyung-A Shin, Seung-Bok Hong, Kyung-Soo Chang
Journal of Bacteriology and Virology.2019; 49(1): 27. CrossRef
Incidence and Overall Survival of Biliary Tract Cancers in South Korea from 2006 to 2015: Using the National Health Information Database
Byung-Woo Kim, Chang-Mo Oh, Hwa Young Choi, Joong-Won Park, Hyunsoon Cho, Moran Ki
Gut and Liver.2019; 13(1): 104. CrossRef
The change in the nationwide seroprevalence of hepatitis C virus and the status of linkage to care in South Korea from 2009 to 2015
Eun Sun Jang, Moran Ki, Hwa Young Choi, Kyung-Ah Kim, Sook-Hyang Jeong
Hepatology International.2019; 13(5): 599. CrossRef
Analysis on Usefulness of Non-invasive Liver Fibrosis Evaluation Method according to the Liver Disease : Focused on H ep atitis C p atients
Nam Ji-Hee, Kim Jung-Hoon
Journal of Radiological Science and Technology.2019; 42(5): 345. CrossRef
Cost-effectiveness of scaling up of hepatitis C screening and treatment: a modelling study in South Korea
Jungyeon Kim, Markus Haacker, Salmaan Keshavjee, Rifat Atun
BMJ Global Health.2019; 4(3): e001441. CrossRef
Updates on Cancer Epidemiology in Korea, 2018
Sun-Seog Kweon
Chonnam Medical Journal.2018; 54(2): 90. CrossRef
Factors influencing on health-related quality of life in South Korean with chronic liver disease
Hyun Jin Kim, Hyeonsik Chu, Seonhye Lee
Health and Quality of Life Outcomes.2018;[Epub] CrossRef
Efficacy and safety of sofosbuvir plus ribavirin for Korean patients with hepatitis C virus genotype 2 infection: A retrospective multi-institutional study
Young Min Kim, Suk Bae Kim, Il Han Song, Sae Hwan Lee, Hong Soo Kim, Tae Hee Lee, Young Woo Kang, Seok Hyun Kim, Byung Seok Lee, Hee Bok Chae, Myeong Jun Song, Ji Woong Jang, Soon Young Ko, Jae Dong Lee
Clinical and Molecular Hepatology.2018; 24(3): 311. CrossRef
Changes in Quality of Life of Chronic Hepatitis C Patients Participating in Clinical Trial
Hoo-Jeung CHO, Euna PARK
JOURNAL OF FISHRIES AND MARINE SCIENCES EDUCATION.2018; 30(5): 1725. CrossRef
Estimation of Direct Medical Costs Related to Chronic Hepatitis C: A Rationale for Early Antiviral Therapy
Do Young Kim
Gut and Liver.2017; 11(6): 745. CrossRef

First
Prev
Page of 1
Next
Last

Search